Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| AQR CAPITAL MANAGEMENT LLC | LATG Chenghe Acquisition I Co. Class A Ordinary Shares | 13G/A | 0% | Dec 31, 2023 | 2y |
| Flagship Ventures Fund V, L.P. | SANA Sana Biotechnology, Inc. | 13G/A | 13% | Dec 31, 2023 | 2y |
| Venrock Healthcare Capital Partners III, L.P. | VRDN Viridian Therapeutics, Inc.DE | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| ForgePoint Cybersecurity GP-I, LLC | ZFOX ZeroFox Holdings, Inc. Common Stock | 13G/A | 4.8% | Dec 31, 2023 | 2y |
| Kynam Capital Management, LP | COGT Cogent Biosciences, Inc. | 13G | 6.8% | Dec 31, 2023 | 2y |
| V. PREM WATSA | FRFHF Fairfax Financial Holdings Ltd | 13G/A | 9.8% | Dec 31, 2023 | 2y |
| Divisadero Street Capital Management, LP | APYX Apyx Medical Corp | 13G/A | 0% | Dec 31, 2023 | 2y |
| MAVERICK CAPITAL LTD | CRIS Curis Inc | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | BJDX Bluejay Diagnostics, Inc. | 13G | 9.99% | Dec 31, 2023 | 2y |
| Berkshire Hathaway Inc | AAPL Apple Inc. | 13G/A | 5.8% | Dec 31, 2023 | 2y |
| Point72 Asset Management, L.P. | ELEV Elevation Oncology, Inc. Common stock | 13G/A | 9.4% | Dec 31, 2023 | 2y |
| BROWN CAPITAL MANAGEMENT LLC | ALRM Alarm.com Holdings, Inc. | 13G/A | 8.99% | Dec 31, 2023 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | HARP Harpoon Therapeutics, Inc. Common Stock | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| FIR TREE CAPITAL MANAGEMENT LP | CSTAF Constellation Acquisition Corp I | 13G | 6.42% | Dec 31, 2023 | 2y |
| FIR TREE CAPITAL MANAGEMENT LP | GODN Golden Star Acquisition Corporation Ordinary Shares | 13G | 6.48% | Dec 31, 2023 | 2y |
| William Carlton Derrick | WHLR Wheeler Real Estate Investment Trust, Inc. | 13G/A | 8.03% | Dec 31, 2023 | 2y |
| Vellar Opportunities Fund Master, Ltd. | AAGR African Agriculture Holdings Inc. Common Stock | 13G/A | 4.86% | Dec 31, 2023 | 2y |
| METEORA CAPITAL, LLC | NKGN NKGen Biotech, Inc. Common Stock | 13G | 7.3% | Dec 31, 2023 | 2y |
| Clal Insurance Enterprises Holdings Ltd | BLZE Backblaze, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Sculptor Capital LP | TWOA two | 13G/A | 0% | Dec 31, 2023 | 2y |
| Venrock Healthcare Capital Partners III, L.P. | APLT Applied Therapeutics, Inc. Common Stock | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | SPXC SPX Technologies, Inc. | 13G | 5.4% | Dec 31, 2023 | 2y |
| Sio Capital Management, LLC | MODD Modular Medical, Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| AQR CAPITAL MANAGEMENT LLC | RMCO Royalty Management Holding Corp | 13G/A | 0.9% | Dec 31, 2023 | 2y |
| Williiam Wei Wang | VZIO VIZIO Holding Corp. | 13G/A | 39% | Dec 31, 2023 | 2y |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | BACA Berenson Acquisition Corp. I | 13G/A | 7.05% | Dec 31, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | CRNX Crinetics Pharmaceuticals, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Empyrean Capital Partners, LP | WPCA Warburg Pincus Capital Corporation I-A | 13G/A | 0% | Dec 31, 2023 | 2y |
| Alberta Investment Management Corp | HAYW Hayward Holdings, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Thomas A. James | RJF Raymond James Financial Inc | 13G/A | 9.3% | Dec 31, 2023 | 2y |
| Alyeska Investment Group, L.P. | TNXP Tonix Pharmaceuticals Holding Corp. | 13G | 9.99% | Dec 31, 2023 | 2y |
| Greenoaks Capital Partners LLC | CVNA Carvana Co. | 13G/A | 5.3% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | NRIX Nurix Therapeutics, Inc. | 13G/A | 4.9% | Dec 31, 2023 | 2y |
| Fort Baker Capital Management LP | UTAA UTA Acquisition Corporation Class A Ordinary Shares | 13G/A | 0% | Dec 31, 2023 | 2y |
| ORBIMED ADVISORS LLC | MREO Mereo BioPharma Group plc | 13G/A | 0% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | TNYA Tenaya Therapeutics, Inc. | 13G/A | 6.7% | Dec 31, 2023 | 2y |
| AMERIPRISE FINANCIAL INC | BUR Burford Capital Ltd | 13G/A | 4.21% | Dec 31, 2023 | 2y |
| TANG CAPITAL MANAGEMENT, LLC | ELEV Elevation Oncology, Inc. Common stock | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| Paradigm Biocapital Advisors LP | OLMA Olema Oncology, Inc. | 13G/A | 14.3% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | EQH Equitable Holdings, Inc. | 13G/A | 8.2% | Dec 31, 2023 | 2y |
| Xinfeng Feng | ATMC AlphaTime Acquisition Corp Ordinary Shares | 13G | 29.37% | Dec 31, 2023 | 2y |
| Aristotle Capital Management, LLC | CTRA Coterra Energy Inc. | 13G/A | 4.85% | Dec 31, 2023 | 2y |
| Index Ventures Growth I (Jersey) L.P. | SQSP Squarespace, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| SIT INVESTMENT ASSOCIATES INC | PAI Western Asset Investment Grade Income Fund Inc. | 13G | 6.85% | Dec 31, 2023 | 2y |
| Almitas Capital LLC | NPCT Nuveen Core Plus Impact Fund | 13G | 5.88% | Dec 31, 2023 | 2y |
| CITADEL ADVISORS LLC | ARTE Artemis Strategic Investment Corporation Class A Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| Electron Capital Partners, LLC | OPAL OPAL Fuels Inc. | 13G/A | 6.4% | Dec 31, 2023 | 2y |
| Berkshire Hathaway Inc | CE Celanese Corp | 13G/A | 0% | Dec 31, 2023 | 2y |
| Avidity Partners Management LP | ALT Altimmune, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | HCVI Hennessy Capital Investment Corp. VI Class A Common Stock | 13G | 7.56% | Dec 31, 2023 | 2y |